Wainer Andrea F's Form 4 filing
Abbott Laboratories (ABT) · filed Feb 27, 2024
- Accession no.
- 0001415889-24-005576
- Filed
- Feb 27, 2024
- Trade date
- Feb 23, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.50M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wainer Andrea FCIK 0001778070 | Officer (EXECUTIVE VICE PRESIDENT) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 23, 2024 | Common shares without par value | MOption exerciseAcquired | +12,500 | $59.94 | +$749,250 | 91,204 | Direct | |
| Feb 23, 2024 | Common shares without par value | SSaleDisposed | −12,500 | $120.00 | −$1,500,000 | 78,704 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 23, 2024 | Common Shares | MOption exerciseDisposed | −12,500 | $0.00 | $0 | 34,449 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.